Who Exports Fluconazole from India — 660 Suppliers Behind a $91.9M Market
India's fluconazole export market is supplied by 660 active exporters who collectively shipped $91.9M across 8,777 shipments. ZYDUS LIFESCIENCES LIMITED leads with a 20.7% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LIMITED and AUROBINDO PHARMA LTD. The top 5 suppliers together control 44.8% of total export value, reflecting a moderately competitive market structure.
Top Fluconazole Exporters from India — Ranked by Export Value
ZYDUS LIFESCIENCES LIMITED is the leading fluconazole exporter from India, holding a 20.7% share of the $91.9M market across 8,777 shipments from 660 exporters. The top 5 suppliers — ZYDUS LIFESCIENCES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, AUROBINDO PHARMA LTD, GLENMARK PHARMACEUTICALS LIMITED, CAPLIN POINT LABORATORIES LIMITED — collectively control 44.8% of total export value, indicating a competitive market. Individual shares are: ZYDUS LIFESCIENCES LIMITED (20.7%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (6.9%), AUROBINDO PHARMA LTD (6.5%), GLENMARK PHARMACEUTICALS LIMITED (5.5%), CAPLIN POINT LABORATORIES LIMITED (5.2%).
Top Fluconazole Exporters from India
Ranked by export value · 660 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED FLUCONAZOLE TABLETS USP 200MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 100MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 200MG 1X30 PACKS) | $19.1M | 6 | 20.7% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED FLUCONAZOLE CAPSULES 50MG PACK : 7S STRIFLUCONAZOLE CAPSULES 150MG PACK :1X1S BAFLUCONAZOLE CAPSULES 200MG PACK : 7S STR | $6.3M | 7 | 6.9% |
| 3 | AUROBINDO PHARMA LTD FLUCONAZOLE TABLETS USP 200MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 100MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 200MG 1X30 PACKS) | $6.0M | 3 | 6.5% |
| 4 | GLENMARK PHARMACEUTICALS LIMITED FLUCONAZOLE TABLETS USP 200MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 100MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 200MG 1X30 PACKS) | $5.0M | 3 | 5.5% |
| 5 | CAPLIN POINT LABORATORIES LIMITED FLUCAPDAZEL KIT EACH KIT CONT FLUCONAZOLE TABLFLUCONAZOLE FOR ORAL SUSPENSION USP 50MG | $4.8M | 11 | 5.2% |
| 6 | DR.REDDY'S LABORATORIES LTD FLUCONAZOLE TABLETS USP 200MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 100MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 200MG 1X30 PACKS) | $3.9M | 1 | 4.2% |
| 7 | CIPLA LIMITED FLUCONAZOLE CAPSULES USP 150MG (FUNGISTOFLUCONAZOLE CAPSULES 150MG (FUNGISTOP 15BIO FLUCONAZOLE 200MG 30'ST SA-HDPE BOT | $2.6M | 14 | 2.8% |
| 8 | AUROBINDO PHARMA LIMITED FLUCONAZOLE TABLETS USP 200MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 100MG 1X100 PACKS)FLUCONAZOLE TABLETS USP 200MG 1X30 PACKS) | $2.6M | 1 | 2.8% |
| 9 | KUSUM HEALTHCARE PRIVATE LIMITED DAZEL KIT EACH KIT CONT FLUCONAZOLE TABL | $2.2M | 11 | 2.4% |
| 10 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED FLUCONAZOLE FOR ORAL SUSPENSION USP 50MGFLUCONAZOLE CAPSULES USP 150MG (FUNGISTOFLUCONAZOLE CAPSULES 150MG (FUNGISTOP 15 | $1.8M | 7 | 2.0% |
| 11 | GRACURE PHARMACEUTICALS LIMITED FLUCONAZOLE CAPSULES 50MG PACK : 7S STRIFLUCONAZOLE CAPSULES 150MG PACK :1X1S BAFLUCONAZOLE CAPSULES 200MG PACK : 7S STR | $1.7M | 2 | 1.9% |
| 12 | KROSYL PHARMACEUTICALS PRIVATE LIMITED FLUCONAZOLE FOR ORAL SUSPENSION USP 50MGANTIFUNGAL DRUGSDR.FLUZO DSPHARMACEUTICAL PRODUCTS MEDICINES - FLUCLOXATRUST CAPS | $1.5M | 1 | 1.6% |
| 13 | AJANTA PHARMA LIMITED FLUCONAZOLE CAPSULES USP 150MG (FUNGISTOFLUCONAZOLE CAPSULES 150MG (FUNGISTOP 15ZOCON 150 MG TABLETS FLUCONAZOLE TABLETS 150 MG 1X1T | $1.5M | 12 | 1.6% |
| 14 | GLOBELA PHARMA PRIVATE LIMITED FLUCONAZOLE FOR ORAL SUSPENSION USP 50MGEVERDESTINY FLUCONAZOLE 200MGKESFLUCAN FLUCONAZOLE CAPSULES 200 MG | $1.5M | 2 | 1.6% |
| 15 | WEXFORD LABORATORIES PRIVATE LIMITED | $1.0M | 6 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Fluconazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter, June 2019 | Yes, as of 2022 | Yes | 51 (2017) | Received FDA warning letter in June 2019 for cGMP deviations at Pydibhimavaram f |
| Zydus Lifesciences Limited | Approved | Yes, as of 2022 | Yes | 77 (2017) | Secured highest number of ANDA approvals among Indian companies in 2017. |
| Glenmark Pharmaceuticals Limited | Warning Letter, October 2 | Yes, as of 2022 | Yes | 18 (2017) | Received FDA warning letter in October 2019 for cGMP violations at Himachal Prad |
| Sun Pharmaceutical Industries Limited | Approved | Yes, as of 2022 | Yes | 22 (2017) | Received 22 ANDA approvals in 2017. |
| Dr. Reddy's Laboratories Ltd | Approved | Yes, as of 2022 | Yes | 10 (2017) | Received 10 ANDA approvals in 2017. |
| Cipla Limited | Approved | Yes, as of 2022 | Yes | 10 (2017) | Received 10 ANDA approvals in 2017. |
| Ajanta Pharma Limited | Approved | Yes, as of 2022 | Yes | 6 (2017) | Received 6 ANDA approvals in 2017. |
| Lupin Limited | Approved | Yes, as of 2022 | Yes | 17 (2017) | Received 17 ANDA approvals in 2017. |
TransData Nexus reviewed the regulatory standing of 8 leading Fluconazole exporters from India. 6 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Fluconazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drugs, including Fluconazole. Notable firms such as Dr. Reddy's Laboratories and Aurobindo Pharma have established significant operations in Hyderabad, enhancing its reputation as a central hub for bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Companies like Zydus Cadila and Alembic Pharmaceuticals have established manufacturing facilities in this region, focusing on producing finished dosage forms, including Fluconazole tablets and capsules. This cluster's emphasis on formulations complements Hyderabad's bulk drug production, creating a comprehensive supply chain for Fluconazole exports.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a strategic export gateway for pharmaceutical products. Its proximity to major ports facilitates efficient international distribution of pharmaceuticals, including Fluconazole. Pharmaceutical companies in this area benefit from well-established logistics and regulatory frameworks, ensuring timely and compliant export operations.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, largely due to favorable tax incentives. This region attracts numerous pharmaceutical companies seeking cost-effective production solutions. While primarily known for domestic supply, its growing infrastructure and policy support position it as a potential contributor to Fluconazole exports.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Leverage Regional Strengths: Source bulk Fluconazole from Hyderabad-based manufacturers and formulations from companies in the Ahmedabad-Vadodara corridor to optimize the supply chain.
- Utilize Export Gateways: Partner with firms in the Mumbai-Thane-Raigad region to streamline export logistics and ensure compliance with international shipping standards.
- Monitor Policy Changes: Stay informed about tax incentives and regulatory developments in regions like Baddi-Nalagarh to capitalize on cost-saving opportunities.
By strategically sourcing from these key pharmaceutical clusters, companies can enhance the efficiency and reliability of their Fluconazole supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Fluconazole exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million
In March 2025, Sun Pharma announced the acquisition of Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. IMPACT: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially increasing its market share and resources for Fluconazole production and export.
Impact: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially increasing its market share and resources for Fluconazole production and export.
Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business, including two U.S. manufacturing sites
In 2025, Zydus Lifesciences acquired the contract development and manufacturing organization (CDMO) business of Agenus, including two biologics manufacturing sites in Emeryville and Berkeley, USA. IMPACT: This acquisition is likely to bolster Zydus' manufacturing capabilities, potentially leading to increased Fluconazole production and export capacity.
Impact: This acquisition is likely to bolster Zydus' manufacturing capabilities, potentially leading to increased Fluconazole production and export capacity.
Aurobindo Pharma Limited — Aurobindo Pharma's arm to acquire 100% membership interest in Lannett Company
In July 2025, Aurobindo Pharma's subsidiary announced plans to acquire 100% membership interest in Lannett Company, a U.S.-based pharmaceutical firm. IMPACT: This acquisition is expected to expand Aurobindo's presence in the U.S. market, potentially enhancing its Fluconazole export capabilities.
Impact: This acquisition is expected to expand Aurobindo's presence in the U.S. market, potentially enhancing its Fluconazole export capabilities.
Common Questions — Fluconazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which fluconazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ZYDUS LIFESCIENCES LIMITED leads with 221 recorded shipments worth $19.1M. SUN PHARMACEUTICAL INDUSTRIES LIMITED (194 shipments) and AUROBINDO PHARMA LTD (257 shipments) are also established high-volume exporters.
Q How many fluconazole manufacturers are there in India?
India has 660 active fluconazole exporters with a combined export market of $91.9M across 8,777 shipments to 153 countries. The top 5 suppliers hold 44.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for fluconazole from India?
Average FOB unit price: $2.91 per unit, ranging from $0.01 to $1867.46. Average shipment value: $10.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 660 verified Indian exporters of Fluconazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 8,777 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 153 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,777 Verified Shipments
660 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists